BindingDB logo
myBDB logout

30 similar compounds to monomer 50008235

Compile data set for download or QSAR
Wt: 1113.3
BDBM50008228
Wt: 993.1
BDBM50008226
Wt: 4642.2
BDBM85163
Wt: 984.1
BDBM50008376
Wt: 998.1
BDBM50008378
Wt: 1026.1
BDBM50012290
Wt: 2296.6
BDBM50012292
Wt: 1854.0
BDBM50012293
Wt: 1184.3
BDBM50012295
Wt: 1382.5
BDBM50012296
Wt: 2889.2
BDBM50172743
Wt: 1839.0
BDBM50172744
Wt: 2060.2
BDBM50187746
Wt: 1195.3
BDBM50191231
Wt: 2437.6
BDBM50196034
Displayed 1 to 15 (of 30 total )  |  Next  |  Last  >>

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 25 hits for monomerid = 50008228,50008226,85163,50008376,50008378,50012290,50012292,50012293,50012295,50012296,50172743,50172744,50187746,50191231,50196034   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Bcl-2-like protein 1


(Homo sapiens (Human))
BDBM50196034
PNG
(CHEMBL410802 | QEDIIRNIARHLAQVGDSMDR)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O
Show InChI InChI=1S/C100H169N35O34S/c1-14-46(8)75(133-90(161)61(36-68(104)139)128-82(153)54(21-18-31-113-99(107)108)124-95(166)76(47(9)15-2)135-96(167)77(48(10)16-3)134-91(162)64(39-73(147)148)130-83(154)56(25-28-70(141)142)122-80(151)52(101)23-26-66(102)137)94(165)118-50(12)79(150)120-53(20-17-30-112-98(105)106)81(152)127-60(35-51-40-111-43-116-51)87(158)126-59(34-44(4)5)86(157)117-49(11)78(149)121-55(24-27-67(103)138)85(156)132-74(45(6)7)93(164)115-41-69(140)119-62(37-71(143)144)88(159)131-65(42-136)92(163)123-57(29-33-170-13)84(155)129-63(38-72(145)146)89(160)125-58(97(168)169)22-19-32-114-100(109)110/h40,43-50,52-65,74-77,136H,14-39,41-42,101H2,1-13H3,(H2,102,137)(H2,103,138)(H2,104,139)(H,111,116)(H,115,164)(H,117,157)(H,118,165)(H,119,140)(H,120,150)(H,121,149)(H,122,151)(H,123,163)(H,124,166)(H,125,160)(H,126,158)(H,127,152)(H,128,153)(H,129,155)(H,130,154)(H,131,159)(H,132,156)(H,133,161)(H,134,162)(H,135,167)(H,141,142)(H,143,144)(H,145,146)(H,147,148)(H,168,169)(H4,105,106,112)(H4,107,108,113)(H4,109,110,114)/t46-,47-,48-,49-,50-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,74-,75-,76-,77-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
7n/an/an/an/an/an/an/an/a



University of Michigan

Curated by ChEMBL


Assay Description
Displacement of FAM-Bak from human Bcl-xL by FP assay


J Med Chem 49: 6139-42 (2006)


Article DOI: 10.1021/jm060460o
BindingDB Entry DOI: 10.7270/Q24M946T
More data for this
Ligand-Target Pair
Apoptosis regulator Bcl-2


(Homo sapiens (Human))
BDBM50196034
PNG
(CHEMBL410802 | QEDIIRNIARHLAQVGDSMDR)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O
Show InChI InChI=1S/C100H169N35O34S/c1-14-46(8)75(133-90(161)61(36-68(104)139)128-82(153)54(21-18-31-113-99(107)108)124-95(166)76(47(9)15-2)135-96(167)77(48(10)16-3)134-91(162)64(39-73(147)148)130-83(154)56(25-28-70(141)142)122-80(151)52(101)23-26-66(102)137)94(165)118-50(12)79(150)120-53(20-17-30-112-98(105)106)81(152)127-60(35-51-40-111-43-116-51)87(158)126-59(34-44(4)5)86(157)117-49(11)78(149)121-55(24-27-67(103)138)85(156)132-74(45(6)7)93(164)115-41-69(140)119-62(37-71(143)144)88(159)131-65(42-136)92(163)123-57(29-33-170-13)84(155)129-63(38-72(145)146)89(160)125-58(97(168)169)22-19-32-114-100(109)110/h40,43-50,52-65,74-77,136H,14-39,41-42,101H2,1-13H3,(H2,102,137)(H2,103,138)(H2,104,139)(H,111,116)(H,115,164)(H,117,157)(H,118,165)(H,119,140)(H,120,150)(H,121,149)(H,122,151)(H,123,163)(H,124,166)(H,125,160)(H,126,158)(H,127,152)(H,128,153)(H,129,155)(H,130,154)(H,131,159)(H,132,156)(H,133,161)(H,134,162)(H,135,167)(H,141,142)(H,143,144)(H,145,146)(H,147,148)(H,168,169)(H4,105,106,112)(H4,107,108,113)(H4,109,110,114)/t46-,47-,48-,49-,50-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,74-,75-,76-,77-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
11n/an/an/an/an/an/an/an/a



University of Michigan

Curated by ChEMBL


Assay Description
Displacement of FAM-Bid from human Bcl2 by FP assay


J Med Chem 49: 6139-42 (2006)


Article DOI: 10.1021/jm060460o
BindingDB Entry DOI: 10.7270/Q24M946T
More data for this
Ligand-Target Pair
Induced myeloid leukemia cell differentiation protein Mcl-1


(Homo sapiens (Human))
BDBM50196034
PNG
(CHEMBL410802 | QEDIIRNIARHLAQVGDSMDR)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O
Show InChI InChI=1S/C100H169N35O34S/c1-14-46(8)75(133-90(161)61(36-68(104)139)128-82(153)54(21-18-31-113-99(107)108)124-95(166)76(47(9)15-2)135-96(167)77(48(10)16-3)134-91(162)64(39-73(147)148)130-83(154)56(25-28-70(141)142)122-80(151)52(101)23-26-66(102)137)94(165)118-50(12)79(150)120-53(20-17-30-112-98(105)106)81(152)127-60(35-51-40-111-43-116-51)87(158)126-59(34-44(4)5)86(157)117-49(11)78(149)121-55(24-27-67(103)138)85(156)132-74(45(6)7)93(164)115-41-69(140)119-62(37-71(143)144)88(159)131-65(42-136)92(163)123-57(29-33-170-13)84(155)129-63(38-72(145)146)89(160)125-58(97(168)169)22-19-32-114-100(109)110/h40,43-50,52-65,74-77,136H,14-39,41-42,101H2,1-13H3,(H2,102,137)(H2,103,138)(H2,104,139)(H,111,116)(H,115,164)(H,117,157)(H,118,165)(H,119,140)(H,120,150)(H,121,149)(H,122,151)(H,123,163)(H,124,166)(H,125,160)(H,126,158)(H,127,152)(H,128,153)(H,129,155)(H,130,154)(H,131,159)(H,132,156)(H,133,161)(H,134,162)(H,135,167)(H,141,142)(H,143,144)(H,145,146)(H,147,148)(H,168,169)(H4,105,106,112)(H4,107,108,113)(H4,109,110,114)/t46-,47-,48-,49-,50-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,74-,75-,76-,77-/m0/s1
PDB
MMDB

NCI pathway
KEGG

B.MOAD
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
12n/an/an/an/an/an/an/an/a



University of Michigan

Curated by ChEMBL


Assay Description
Displacement of FAM-Bid from human Mcl1 by FP assay


J Med Chem 49: 6139-42 (2006)


Article DOI: 10.1021/jm060460o
BindingDB Entry DOI: 10.7270/Q24M946T
More data for this
Ligand-Target Pair
Galanin receptor 2


(RAT)
BDBM85163
PNG
(GMAP (1-41))
Show SMILES CCC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)C1CCCN1C(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](N)CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)O)C(=O)N[C@@H](C(C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O
Show InChI InChI=1S/C206H327N57O63S/c1-24-107(15)163(199(322)242-123(53-40-77-221-205(215)216)183(306)261-165(114(22)265)201(324)260-164(108(16)25-2)200(323)243-130(73-81-327-23)182(305)237-128(62-70-157(277)278)179(302)253-141(90-117-48-33-28-34-49-117)191(314)250-134(83-102(5)6)184(307)231-112(20)170(293)247-140(89-116-46-31-27-32-47-116)190(313)251-138(87-106(13)14)188(311)254-142(91-118-95-219-100-226-118)192(315)252-137(86-105(11)12)185(308)234-121(51-36-38-75-208)176(299)236-126(60-68-155(273)274)174(297)228-109(17)167(290)224-98-152(269)227-110(18)168(291)246-133(166(212)289)82-101(3)4)259-171(294)113(21)230-173(296)120(50-35-37-74-207)233-193(316)143(92-160(283)284)255-178(301)124(58-65-149(210)266)240-196(319)146(99-264)258-181(304)125(59-66-150(211)267)238-186(309)136(85-104(9)10)249-177(300)122(52-39-76-220-204(213)214)235-194(317)145(94-162(287)288)257-189(312)139(88-115-44-29-26-30-45-115)232-153(270)97-223-151(268)96-225-197(320)147-55-42-79-262(147)202(325)131(54-41-78-222-206(217)218)244-169(292)111(19)229-175(298)127(61-69-156(275)276)239-195(318)144(93-161(285)286)256-180(303)129(63-71-158(279)280)241-198(321)148-56-43-80-263(148)203(326)132(64-72-159(281)282)245-187(310)135(84-103(7)8)248-172(295)119(209)57-67-154(271)272/h26-34,44-49,95,100-114,119-148,163-165,264-265H,24-25,35-43,50-94,96-99,207-209H2,1-23H3,(H2,210,266)(H2,211,267)(H2,212,289)(H,219,226)(H,223,268)(H,224,290)(H,225,320)(H,227,269)(H,228,297)(H,229,298)(H,230,296)(H,231,307)(H,232,270)(H,233,316)(H,234,308)(H,235,317)(H,236,299)(H,237,305)(H,238,309)(H,239,318)(H,240,319)(H,241,321)(H,242,322)(H,243,323)(H,244,292)(H,245,310)(H,246,291)(H,247,293)(H,248,295)(H,249,300)(H,250,314)(H,251,313)(H,252,315)(H,253,302)(H,254,311)(H,255,301)(H,256,303)(H,257,312)(H,258,304)(H,259,294)(H,260,324)(H,261,306)(H,271,272)(H,273,274)(H,275,276)(H,277,278)(H,279,280)(H,281,282)(H,283,284)(H,285,286)(H,287,288)(H4,213,214,220)(H4,215,216,221)(H4,217,218,222)/t107?,108?,109-,110-,111-,112-,113-,114?,119+,120-,121+,122+,123-,124-,125-,126-,127-,128+,129-,130-,131+,132-,133-,134-,135+,136+,137+,138-,139+,140-,141+,142-,143-,144+,145+,146-,147?,148-,163-,164-,165-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem

Similars

Article
PubMed
840n/an/an/an/an/an/an/an/a



The Schering-Plough Research Institute

Curated by PDSP Ki Database




Mol Pharmacol 52: 337-43 (1997)


Article DOI: 10.1124/mol.52.3.337
BindingDB Entry DOI: 10.7270/Q23T9FRG
More data for this
Ligand-Target Pair
GALR3


(RAT)
BDBM85163
PNG
(GMAP (1-41))
Show SMILES CCC(C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@@H](Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)C1CCCN1C(=O)[C@@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](N)CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)O)C(=O)N[C@@H](C(C)CC)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O
Show InChI InChI=1S/C206H327N57O63S/c1-24-107(15)163(199(322)242-123(53-40-77-221-205(215)216)183(306)261-165(114(22)265)201(324)260-164(108(16)25-2)200(323)243-130(73-81-327-23)182(305)237-128(62-70-157(277)278)179(302)253-141(90-117-48-33-28-34-49-117)191(314)250-134(83-102(5)6)184(307)231-112(20)170(293)247-140(89-116-46-31-27-32-47-116)190(313)251-138(87-106(13)14)188(311)254-142(91-118-95-219-100-226-118)192(315)252-137(86-105(11)12)185(308)234-121(51-36-38-75-208)176(299)236-126(60-68-155(273)274)174(297)228-109(17)167(290)224-98-152(269)227-110(18)168(291)246-133(166(212)289)82-101(3)4)259-171(294)113(21)230-173(296)120(50-35-37-74-207)233-193(316)143(92-160(283)284)255-178(301)124(58-65-149(210)266)240-196(319)146(99-264)258-181(304)125(59-66-150(211)267)238-186(309)136(85-104(9)10)249-177(300)122(52-39-76-220-204(213)214)235-194(317)145(94-162(287)288)257-189(312)139(88-115-44-29-26-30-45-115)232-153(270)97-223-151(268)96-225-197(320)147-55-42-79-262(147)202(325)131(54-41-78-222-206(217)218)244-169(292)111(19)229-175(298)127(61-69-156(275)276)239-195(318)144(93-161(285)286)256-180(303)129(63-71-158(279)280)241-198(321)148-56-43-80-263(148)203(326)132(64-72-159(281)282)245-187(310)135(84-103(7)8)248-172(295)119(209)57-67-154(271)272/h26-34,44-49,95,100-114,119-148,163-165,264-265H,24-25,35-43,50-94,96-99,207-209H2,1-23H3,(H2,210,266)(H2,211,267)(H2,212,289)(H,219,226)(H,223,268)(H,224,290)(H,225,320)(H,227,269)(H,228,297)(H,229,298)(H,230,296)(H,231,307)(H,232,270)(H,233,316)(H,234,308)(H,235,317)(H,236,299)(H,237,305)(H,238,309)(H,239,318)(H,240,319)(H,241,321)(H,242,322)(H,243,323)(H,244,292)(H,245,310)(H,246,291)(H,247,293)(H,248,295)(H,249,300)(H,250,314)(H,251,313)(H,252,315)(H,253,302)(H,254,311)(H,255,301)(H,256,303)(H,257,312)(H,258,304)(H,259,294)(H,260,324)(H,261,306)(H,271,272)(H,273,274)(H,275,276)(H,277,278)(H,279,280)(H,281,282)(H,283,284)(H,285,286)(H,287,288)(H4,213,214,220)(H4,215,216,221)(H4,217,218,222)/t107?,108?,109-,110-,111-,112-,113-,114?,119+,120-,121+,122+,123-,124-,125-,126-,127-,128+,129-,130-,131+,132-,133-,134-,135+,136+,137+,138-,139+,140-,141+,142-,143-,144+,145+,146-,147?,148-,163-,164-,165-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

GoogleScholar
PC cid
PC sid
UniChem

Similars

Article
PubMed
1.00E+3n/an/an/an/an/an/an/an/a



Schering-Plough Research Institute

Curated by PDSP Ki Database




J Biol Chem 272: 31949-52 (1997)


Article DOI: 10.1021/acschembio.5b00291
BindingDB Entry DOI: 10.7270/Q21Z42ZG
More data for this
Ligand-Target Pair
C5a anaphylatoxin chemotactic receptor (C5aR)


(Homo sapiens (Human))
BDBM50008228
PNG
(2-[2-(2-{2-[2-(2-{2-[2-Acetylamino-3-(3H-imidazol-...)
Show SMILES CC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC1CCCCC1)C(=O)N[C@@H](CC1CCCCC1)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(O)=O
Show InChI InChI=1S/C53H88N14O12/c1-32(68)61-42(27-36-29-57-31-60-36)50(76)63-37(20-11-12-22-54)47(73)67-43(28-45(70)71)51(77)66-41(26-35-18-9-4-10-19-35)49(75)65-40(25-34-16-7-3-8-17-34)48(74)64-39(24-33-14-5-2-6-15-33)46(72)59-30-44(69)62-38(52(78)79)21-13-23-58-53(55)56/h29,31,33-35,37-43H,2-28,30,54H2,1H3,(H,57,60)(H,59,72)(H,61,68)(H,62,69)(H,63,76)(H,64,74)(H,65,75)(H,66,77)(H,67,73)(H,70,71)(H,78,79)(H4,55,56,58)/t37-,38-,39-,40-,41-,42-,43-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
2.50E+4n/an/an/an/an/an/an/an/a



Abbott Laboratories

Curated by ChEMBL


Assay Description
Ability to inhibit the binding of [125I]-C5a anaphylatoxin chemotactic receptor to polymorphonuclear leukocyte (PMNL) membrane receptor


J Med Chem 35: 220-3 (1992)


Article DOI: 10.1021/jm00080a004
BindingDB Entry DOI: 10.7270/Q21G0K7X
More data for this
Ligand-Target Pair
C5a anaphylatoxin chemotactic receptor (C5aR)


(Homo sapiens (Human))
BDBM50012292
PNG
(AcMet-Val-Val-Ala-Ser-Gln-Leu-Arg-Ala-Asn-Ile-Ser-...)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(C)=O)C(C)C)C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O
Show InChI InChI=1S/C96H166N32O29S2/c1-16-49(10)75(93(155)125-67(43-130)90(152)122-63(37-53-40-105-44-109-53)86(148)114-54(21-17-18-30-97)80(142)123-65(39-72(136)137)87(149)118-59(29-34-159-15)83(145)116-56(24-26-68(98)132)81(143)120-61(35-45(2)3)78(140)108-41-71(135)113-60(94(156)157)23-20-32-107-96(103)104)128-88(150)64(38-70(100)134)119-76(138)50(11)110-79(141)55(22-19-31-106-95(101)102)115-85(147)62(36-46(4)5)121-82(144)57(25-27-69(99)133)117-89(151)66(42-129)124-77(139)51(12)111-91(153)73(47(6)7)127-92(154)74(48(8)9)126-84(146)58(28-33-158-14)112-52(13)131/h40,44-51,54-67,73-75,129-130H,16-39,41-43,97H2,1-15H3,(H2,98,132)(H2,99,133)(H2,100,134)(H,105,109)(H,108,140)(H,110,141)(H,111,153)(H,112,131)(H,113,135)(H,114,148)(H,115,147)(H,116,145)(H,117,151)(H,118,149)(H,119,138)(H,120,143)(H,121,144)(H,122,152)(H,123,142)(H,124,139)(H,125,155)(H,126,146)(H,127,154)(H,128,150)(H,136,137)(H,156,157)(H4,101,102,106)(H4,103,104,107)/t49-,50-,51-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,73-,74-,75-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
5.00E+4n/an/an/an/an/an/an/an/a



Abbott Laboratories

Curated by ChEMBL


Assay Description
Inhibition of [125I]-C5a anaphylatoxin chemotactic receptor binding to PMNL membranes.


J Med Chem 34: 2068-71 (1991)


Article DOI: 10.1021/jm00111a022
BindingDB Entry DOI: 10.7270/Q21Z43C8
More data for this
Ligand-Target Pair
C5a anaphylatoxin chemotactic receptor (C5aR)


(Homo sapiens (Human))
BDBM50012296
PNG
(Ac-Ile-Ser-His-Lys-Asp-Met-Gln-Leu-Arg-Gly-Arg | C...)
Show SMILES CC[C@H](C)[C@H](NC(C)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O
Show InChI InChI=1S/C57H99N21O17S/c1-7-30(4)45(69-31(5)80)54(93)78-41(27-79)53(92)76-39(23-32-25-64-28-68-32)51(90)72-34(12-8-9-18-58)47(86)77-40(24-44(83)84)52(91)74-36(17-21-96-6)49(88)73-35(15-16-42(59)81)48(87)75-38(22-29(2)3)50(89)71-33(13-10-19-65-56(60)61)46(85)67-26-43(82)70-37(55(94)95)14-11-20-66-57(62)63/h25,28-30,33-41,45,79H,7-24,26-27,58H2,1-6H3,(H2,59,81)(H,64,68)(H,67,85)(H,69,80)(H,70,82)(H,71,89)(H,72,90)(H,73,88)(H,74,91)(H,75,87)(H,76,92)(H,77,86)(H,78,93)(H,83,84)(H,94,95)(H4,60,61,65)(H4,62,63,66)/t30-,33-,34-,35-,36-,37-,38-,39-,40-,41-,45-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
1.00E+5n/an/an/an/an/an/an/an/a



Abbott Laboratories

Curated by ChEMBL


Assay Description
Compound was tested for the inhibition of [125I]-C5a binding to C5a anaphylatoxin chemotactic receptor binding to PMNL membranes.


J Med Chem 34: 2068-71 (1991)


Article DOI: 10.1021/jm00111a022
BindingDB Entry DOI: 10.7270/Q21Z43C8
More data for this
Ligand-Target Pair
C5a anaphylatoxin chemotactic receptor (C5aR)


(Homo sapiens (Human))
BDBM50012290
PNG
(2-[2-(2-{2-[2-(2-{2-[2-Acetylamino-3-(3H-imidazol-...)
Show SMILES CSCC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1cnc[nH]1)NC(C)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O
Show InChI InChI=1S/C42H71N15O13S/c1-22(2)16-29(35(63)49-20-33(60)52-28(41(69)70)9-7-14-48-42(45)46)56-37(65)26(10-11-32(44)59)54-38(66)27(12-15-71-4)55-40(68)31(18-34(61)62)57-36(64)25(8-5-6-13-43)53-39(67)30(51-23(3)58)17-24-19-47-21-50-24/h19,21-22,25-31H,5-18,20,43H2,1-4H3,(H2,44,59)(H,47,50)(H,49,63)(H,51,58)(H,52,60)(H,53,67)(H,54,66)(H,55,68)(H,56,65)(H,57,64)(H,61,62)(H,69,70)(H4,45,46,48)/t25-,26-,27-,28-,29-,30-,31-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
1.50E+5n/an/an/an/an/an/an/an/a



Abbott Laboratories

Curated by ChEMBL


Assay Description
Inhibition of [125I]-C5a binding to C5a anaphylatoxin chemotactic receptor in PMNL membranes


J Med Chem 34: 2068-71 (1991)


Article DOI: 10.1021/jm00111a022
BindingDB Entry DOI: 10.7270/Q21Z43C8
More data for this
Ligand-Target Pair
C5a anaphylatoxin chemotactic receptor (C5aR)


(Homo sapiens (Human))
BDBM50008378
PNG
(CHEMBL129978 | H-His(1Me)-Lys-AspMet-GIn-Leu-Gly-A...)
Show SMILES CSCC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1cncn1C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O
Show InChI InChI=1S/C41H71N15O12S/c1-22(2)16-29(35(62)49-20-32(58)50-28(40(67)68)9-7-14-48-41(45)46)54-37(64)26(10-11-31(44)57)52-38(65)27(12-15-69-4)53-39(66)30(18-33(59)60)55-36(63)25(8-5-6-13-42)51-34(61)24(43)17-23-19-47-21-56(23)3/h19,21-22,24-30H,5-18,20,42-43H2,1-4H3,(H2,44,57)(H,49,62)(H,50,58)(H,51,61)(H,52,65)(H,53,66)(H,54,64)(H,55,63)(H,59,60)(H,67,68)(H4,45,46,48)/t24-,25-,26-,27-,28-,29-,30-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
1.80E+5n/an/an/an/an/an/an/an/a



Abbott Laboratories

Curated by ChEMBL


Assay Description
Inhibitory activity against [125I]-rC5a binding to C5a anaphylatoxin chemotactic receptor in human polymorphonuclear leukocyte (PMNL) membranes


J Med Chem 35: 402-6 (1992)


Article DOI: 10.1021/jm00080a030
BindingDB Entry DOI: 10.7270/Q2HH6J1S
More data for this
Ligand-Target Pair
C5a anaphylatoxin chemotactic receptor (C5aR)


(Homo sapiens (Human))
BDBM50008226
PNG
(2-[2-(2-{2-[2-(2-{2-[2-Acetylamino-3-(3H-imidazol-...)
Show SMILES CCCC[C@H](NC(=O)[C@H](CCCC)NC(=O)[C@H](CCCC)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]cn1)NC(C)=O)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(O)=O
Show InChI InChI=1S/C44H76N14O12/c1-5-8-14-28(37(63)50-24-35(60)53-32(43(69)70)18-13-20-49-44(46)47)54-38(64)29(15-9-6-2)55-39(65)30(16-10-7-3)56-42(68)34(22-36(61)62)58-40(66)31(17-11-12-19-45)57-41(67)33(52-26(4)59)21-27-23-48-25-51-27/h23,25,28-34H,5-22,24,45H2,1-4H3,(H,48,51)(H,50,63)(H,52,59)(H,53,60)(H,54,64)(H,55,65)(H,56,68)(H,57,67)(H,58,66)(H,61,62)(H,69,70)(H4,46,47,49)/t28-,29-,30-,31-,32-,33-,34-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
2.10E+5n/an/an/an/an/an/an/an/a



Abbott Laboratories

Curated by ChEMBL


Assay Description
Ability to inhibit the binding of [125I]-C5a anaphylatoxin chemotactic receptor to polymorphonuclear leukocyte (PMNL) membrane receptor


J Med Chem 35: 220-3 (1992)


Article DOI: 10.1021/jm00080a004
BindingDB Entry DOI: 10.7270/Q21G0K7X
More data for this
Ligand-Target Pair
C5a anaphylatoxin chemotactic receptor (C5aR)


(Homo sapiens (Human))
BDBM50012293
PNG
(CHEMBL409278 | Ser-Gln-Leu-Alr-Ala-Asn-Ile-Ser-His...)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O
Show InChI InChI=1S/C76H132N28O24S/c1-9-38(6)59(104-71(124)51(29-56(81)109)98-60(113)39(7)91-63(116)43(15-12-23-87-75(82)83)95-68(121)49(27-37(4)5)100-65(118)44(17-19-54(79)107)93-61(114)41(78)33-105)73(126)103-53(34-106)72(125)101-50(28-40-31-86-35-90-40)69(122)94-42(14-10-11-22-77)64(117)102-52(30-58(111)112)70(123)97-46(21-25-129-8)67(120)96-45(18-20-55(80)108)66(119)99-48(26-36(2)3)62(115)89-32-57(110)92-47(74(127)128)16-13-24-88-76(84)85/h31,35-39,41-53,59,105-106H,9-30,32-34,77-78H2,1-8H3,(H2,79,107)(H2,80,108)(H2,81,109)(H,86,90)(H,89,115)(H,91,116)(H,92,110)(H,93,114)(H,94,122)(H,95,121)(H,96,120)(H,97,123)(H,98,113)(H,99,119)(H,100,118)(H,101,125)(H,102,117)(H,103,126)(H,104,124)(H,111,112)(H,127,128)(H4,82,83,87)(H4,84,85,88)/t38-,39-,41-,42-,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,59-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
3.00E+5n/an/an/an/an/an/an/an/a



Abbott Laboratories

Curated by ChEMBL


Assay Description
Compound was tested for the inhibition of [125I]-C5a anaphylatoxin chemotactic receptor binding to PMNL membranes at a concentration of 0.1-1 mM


J Med Chem 34: 2068-71 (1991)


Article DOI: 10.1021/jm00111a022
BindingDB Entry DOI: 10.7270/Q21Z43C8
More data for this
Ligand-Target Pair
C5a anaphylatoxin chemotactic receptor (C5aR)


(Homo sapiens (Human))
BDBM50008376
PNG
(2-[2-(2-{2-[2-(2-{6-Amino-2-[2-amino-3-(3H-imidazo...)
Show SMILES CSCC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O
Show InChI InChI=1S/C40H69N15O12S/c1-21(2)15-28(34(61)48-19-31(57)50-27(39(66)67)8-6-13-47-40(44)45)54-36(63)25(9-10-30(43)56)52-37(64)26(11-14-68-3)53-38(65)29(17-32(58)59)55-35(62)24(7-4-5-12-41)51-33(60)23(42)16-22-18-46-20-49-22/h18,20-21,23-29H,4-17,19,41-42H2,1-3H3,(H2,43,56)(H,46,49)(H,48,61)(H,50,57)(H,51,60)(H,52,64)(H,53,65)(H,54,63)(H,55,62)(H,58,59)(H,66,67)(H4,44,45,47)/t23-,24-,25-,26-,27-,28-,29-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
3.00E+5n/an/an/an/an/an/an/an/a



Abbott Laboratories

Curated by ChEMBL


Assay Description
Inhibition of [125I]-C5a binding to C5a anaphylatoxin chemotactic receptor in PMNL membranes


J Med Chem 34: 2068-71 (1991)


Article DOI: 10.1021/jm00111a022
BindingDB Entry DOI: 10.7270/Q21Z43C8
More data for this
Ligand-Target Pair
C5a anaphylatoxin chemotactic receptor (C5aR)


(Homo sapiens (Human))
BDBM50012295
PNG
(CHEMBL217378 | ISHKDMQLGR | Ile-Ser-His-Lys-Asp-Me...)
Show SMILES CC[C@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O
Show InChI InChI=1S/C49H85N17O15S/c1-6-26(4)39(52)47(79)66-35(23-67)46(78)64-33(19-27-21-55-24-58-27)44(76)60-28(10-7-8-15-50)41(73)65-34(20-38(70)71)45(77)62-30(14-17-82-5)43(75)61-29(12-13-36(51)68)42(74)63-32(18-25(2)3)40(72)57-22-37(69)59-31(48(80)81)11-9-16-56-49(53)54/h21,24-26,28-35,39,67H,6-20,22-23,50,52H2,1-5H3,(H2,51,68)(H,55,58)(H,57,72)(H,59,69)(H,60,76)(H,61,75)(H,62,77)(H,63,74)(H,64,78)(H,65,73)(H,66,79)(H,70,71)(H,80,81)(H4,53,54,56)/t26-,28-,29-,30-,31-,32-,33-,34-,35-,39-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
3.00E+5n/an/an/an/an/an/an/an/a



Abbott Laboratories

Curated by ChEMBL


Assay Description
Inhibition of [125I]-C5a binding to C5a anaphylatoxin chemotactic receptor in PMNL membranes


J Med Chem 34: 2068-71 (1991)


Article DOI: 10.1021/jm00111a022
BindingDB Entry DOI: 10.7270/Q21Z43C8
More data for this
Ligand-Target Pair
C5a anaphylatoxin chemotactic receptor (C5aR)


(Homo sapiens (Human))
BDBM50008376
PNG
(2-[2-(2-{2-[2-(2-{6-Amino-2-[2-amino-3-(3H-imidazo...)
Show SMILES CSCC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O
Show InChI InChI=1S/C40H69N15O12S/c1-21(2)15-28(34(61)48-19-31(57)50-27(39(66)67)8-6-13-47-40(44)45)54-36(63)25(9-10-30(43)56)52-37(64)26(11-14-68-3)53-38(65)29(17-32(58)59)55-35(62)24(7-4-5-12-41)51-33(60)23(42)16-22-18-46-20-49-22/h18,20-21,23-29H,4-17,19,41-42H2,1-3H3,(H2,43,56)(H,46,49)(H,48,61)(H,50,57)(H,51,60)(H,52,64)(H,53,65)(H,54,63)(H,55,62)(H,58,59)(H,66,67)(H4,44,45,47)/t23-,24-,25-,26-,27-,28-,29-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
3.00E+5n/an/an/an/an/an/an/an/a



Abbott Laboratories

Curated by ChEMBL


Assay Description
Inhibitory activity against [125I]-rC5a binding to C5a anaphylatoxin chemotactic receptor in human polymorphonuclear leukocyte (PMNL) membranes


J Med Chem 35: 402-6 (1992)


Article DOI: 10.1021/jm00080a030
BindingDB Entry DOI: 10.7270/Q2HH6J1S
More data for this
Ligand-Target Pair
Bcl-2-like protein 1


(Homo sapiens (Human))
BDBM50196034
PNG
(CHEMBL410802 | QEDIIRNIARHLAQVGDSMDR)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O
Show InChI InChI=1S/C100H169N35O34S/c1-14-46(8)75(133-90(161)61(36-68(104)139)128-82(153)54(21-18-31-113-99(107)108)124-95(166)76(47(9)15-2)135-96(167)77(48(10)16-3)134-91(162)64(39-73(147)148)130-83(154)56(25-28-70(141)142)122-80(151)52(101)23-26-66(102)137)94(165)118-50(12)79(150)120-53(20-17-30-112-98(105)106)81(152)127-60(35-51-40-111-43-116-51)87(158)126-59(34-44(4)5)86(157)117-49(11)78(149)121-55(24-27-67(103)138)85(156)132-74(45(6)7)93(164)115-41-69(140)119-62(37-71(143)144)88(159)131-65(42-136)92(163)123-57(29-33-170-13)84(155)129-63(38-72(145)146)89(160)125-58(97(168)169)22-19-32-114-100(109)110/h40,43-50,52-65,74-77,136H,14-39,41-42,101H2,1-13H3,(H2,102,137)(H2,103,138)(H2,104,139)(H,111,116)(H,115,164)(H,117,157)(H,118,165)(H,119,140)(H,120,150)(H,121,149)(H,122,151)(H,123,163)(H,124,166)(H,125,160)(H,126,158)(H,127,152)(H,128,153)(H,129,155)(H,130,154)(H,131,159)(H,132,156)(H,133,161)(H,134,162)(H,135,167)(H,141,142)(H,143,144)(H,145,146)(H,147,148)(H,168,169)(H4,105,106,112)(H4,107,108,113)(H4,109,110,114)/t46-,47-,48-,49-,50-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,74-,75-,76-,77-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 65n/an/an/an/an/an/a



University of Michigan

Curated by ChEMBL


Assay Description
Displacement of FAM-Bak from human Bcl-xL by FP assay


J Med Chem 49: 6139-42 (2006)


Article DOI: 10.1021/jm060460o
BindingDB Entry DOI: 10.7270/Q24M946T
More data for this
Ligand-Target Pair
Induced myeloid leukemia cell differentiation protein Mcl-1


(Homo sapiens (Human))
BDBM50196034
PNG
(CHEMBL410802 | QEDIIRNIARHLAQVGDSMDR)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O
Show InChI InChI=1S/C100H169N35O34S/c1-14-46(8)75(133-90(161)61(36-68(104)139)128-82(153)54(21-18-31-113-99(107)108)124-95(166)76(47(9)15-2)135-96(167)77(48(10)16-3)134-91(162)64(39-73(147)148)130-83(154)56(25-28-70(141)142)122-80(151)52(101)23-26-66(102)137)94(165)118-50(12)79(150)120-53(20-17-30-112-98(105)106)81(152)127-60(35-51-40-111-43-116-51)87(158)126-59(34-44(4)5)86(157)117-49(11)78(149)121-55(24-27-67(103)138)85(156)132-74(45(6)7)93(164)115-41-69(140)119-62(37-71(143)144)88(159)131-65(42-136)92(163)123-57(29-33-170-13)84(155)129-63(38-72(145)146)89(160)125-58(97(168)169)22-19-32-114-100(109)110/h40,43-50,52-65,74-77,136H,14-39,41-42,101H2,1-13H3,(H2,102,137)(H2,103,138)(H2,104,139)(H,111,116)(H,115,164)(H,117,157)(H,118,165)(H,119,140)(H,120,150)(H,121,149)(H,122,151)(H,123,163)(H,124,166)(H,125,160)(H,126,158)(H,127,152)(H,128,153)(H,129,155)(H,130,154)(H,131,159)(H,132,156)(H,133,161)(H,134,162)(H,135,167)(H,141,142)(H,143,144)(H,145,146)(H,147,148)(H,168,169)(H4,105,106,112)(H4,107,108,113)(H4,109,110,114)/t46-,47-,48-,49-,50-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,74-,75-,76-,77-/m0/s1
PDB
MMDB

NCI pathway
KEGG

B.MOAD
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 52n/an/an/an/an/an/a



University of Michigan

Curated by ChEMBL


Assay Description
Displacement of FAM-Bid from human Mcl1 by FP assay


J Med Chem 49: 6139-42 (2006)


Article DOI: 10.1021/jm060460o
BindingDB Entry DOI: 10.7270/Q24M946T
More data for this
Ligand-Target Pair
Apoptosis regulator Bcl-2


(Homo sapiens (Human))
BDBM50172743
PNG
(CHEMBL438732 | QEDIIRNIARHLAQVGDSMDRSIPPG)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(N)=O)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(O)=O
Show InChI InChI=1S/C121H202N40O40S/c1-16-57(9)91(156-108(191)73(45-83(125)166)150-99(182)67(27-22-39-135-121(130)131)147-115(198)92(58(10)17-2)158-116(199)93(59(11)18-3)157-109(192)76(48-88(174)175)152-101(184)69(32-35-85(168)169)144-97(180)64(122)30-33-81(123)164)114(197)140-62(14)96(179)142-65(25-20-37-133-119(126)127)98(181)149-72(44-63-49-132-54-138-63)105(188)148-71(43-55(5)6)104(187)139-61(13)95(178)143-68(31-34-82(124)165)103(186)155-90(56(7)8)113(196)136-50-84(167)141-74(46-86(170)171)106(189)154-77(52-162)110(193)146-70(36-42-202-15)102(185)151-75(47-87(172)173)107(190)145-66(26-21-38-134-120(128)129)100(183)153-78(53-163)111(194)159-94(60(12)19-4)118(201)161-41-24-29-80(161)117(200)160-40-23-28-79(160)112(195)137-51-89(176)177/h49,54-62,64-80,90-94,162-163H,16-48,50-53,122H2,1-15H3,(H2,123,164)(H2,124,165)(H2,125,166)(H,132,138)(H,136,196)(H,137,195)(H,139,187)(H,140,197)(H,141,167)(H,142,179)(H,143,178)(H,144,180)(H,145,190)(H,146,193)(H,147,198)(H,148,188)(H,149,181)(H,150,182)(H,151,185)(H,152,184)(H,153,183)(H,154,189)(H,155,186)(H,156,191)(H,157,192)(H,158,199)(H,159,194)(H,168,169)(H,170,171)(H,172,173)(H,174,175)(H,176,177)(H4,126,127,133)(H4,128,129,134)(H4,130,131,135)/t57-,58-,59-,60-,61-,62-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,90-,91-,92-,93-,94-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 1.41E+4n/an/an/an/an/an/a



University of Illinois at Urbana-Champaign

Curated by ChEMBL


Assay Description
Inhibition of BCL2 by fluorescence polarization based competitive binding assay


Bioorg Med Chem Lett 15: 4467-9 (2005)


Article DOI: 10.1016/j.bmcl.2005.07.031
BindingDB Entry DOI: 10.7270/Q2VD6Z0C
More data for this
Ligand-Target Pair
Apoptosis regulator Bcl-2


(Homo sapiens (Human))
BDBM50172744
PNG
(CHEMBL413158 | RNIARHLAQVGDSMDR)
Show SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O
Show InChI InChI=1S/C74H127N29O24S/c1-10-35(6)56(103-67(122)46(26-51(77)106)97-59(114)39(75)14-11-20-85-72(78)79)70(125)91-37(8)58(113)93-40(15-12-21-86-73(80)81)60(115)99-45(25-38-29-84-32-89-38)64(119)98-44(24-33(2)3)63(118)90-36(7)57(112)94-41(17-18-50(76)105)62(117)102-55(34(4)5)69(124)88-30-52(107)92-47(27-53(108)109)65(120)101-49(31-104)68(123)95-42(19-23-128-9)61(116)100-48(28-54(110)111)66(121)96-43(71(126)127)16-13-22-87-74(82)83/h29,32-37,39-49,55-56,104H,10-28,30-31,75H2,1-9H3,(H2,76,105)(H2,77,106)(H,84,89)(H,88,124)(H,90,118)(H,91,125)(H,92,107)(H,93,113)(H,94,112)(H,95,123)(H,96,121)(H,97,114)(H,98,119)(H,99,115)(H,100,116)(H,101,120)(H,102,117)(H,103,122)(H,108,109)(H,110,111)(H,126,127)(H4,78,79,85)(H4,80,81,86)(H4,82,83,87)/t35-,36-,37-,39-,40-,41-,42-,43-,44-,45-,46-,47-,48-,49-,55-,56-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
CHEMBL
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 2.23E+4n/an/an/an/an/an/a



University of Illinois at Urbana-Champaign

Curated by ChEMBL


Assay Description
Inhibition of BCL2 by fluorescence polarization based competitive binding assay


Bioorg Med Chem Lett 15: 4467-9 (2005)


Article DOI: 10.1016/j.bmcl.2005.07.031
BindingDB Entry DOI: 10.7270/Q2VD6Z0C
More data for this
Ligand-Target Pair
Human immunodeficiency virus type 1 integrase


(Human immunodeficiency virus 1)
BDBM50191231
PNG
(CHEMBL413690 | H-VRDQAEHLKT-NH2)
Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(N)=O
Show InChI InChI=1S/C50H86N18O16/c1-23(2)18-32(46(81)62-28(10-7-8-16-51)45(80)68-39(26(6)69)40(54)75)65-47(82)33(19-27-21-57-22-59-27)66-44(79)31(13-15-36(71)72)61-41(76)25(5)60-42(77)30(12-14-35(52)70)63-48(83)34(20-37(73)74)67-43(78)29(11-9-17-58-50(55)56)64-49(84)38(53)24(3)4/h21-26,28-34,38-39,69H,7-20,51,53H2,1-6H3,(H2,52,70)(H2,54,75)(H,57,59)(H,60,77)(H,61,76)(H,62,81)(H,63,83)(H,64,84)(H,65,82)(H,66,79)(H,67,78)(H,68,80)(H,71,72)(H,73,74)(H4,55,56,58)/t25-,26+,28-,29-,30-,31-,32-,33-,34-,38-,39-/m0/s1
PDB
MMDB

UniProtKB/TrEMBL

B.MOAD
DrugBank
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a>2.00E+6n/an/an/an/an/an/a



Graduate School of the Chinese Academy of Sciences

Curated by ChEMBL


Assay Description
Inhibition of wild type HIV1 integrase 3' processing activity


J Med Chem 49: 4477-86 (2006)


Article DOI: 10.1021/jm060307u
BindingDB Entry DOI: 10.7270/Q2736QJZ
More data for this
Ligand-Target Pair
Human immunodeficiency virus type 1 integrase


(Human immunodeficiency virus 1)
BDBM50191231
PNG
(CHEMBL413690 | H-VRDQAEHLKT-NH2)
Show SMILES CC(C)C[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(N)=O
Show InChI InChI=1S/C50H86N18O16/c1-23(2)18-32(46(81)62-28(10-7-8-16-51)45(80)68-39(26(6)69)40(54)75)65-47(82)33(19-27-21-57-22-59-27)66-44(79)31(13-15-36(71)72)61-41(76)25(5)60-42(77)30(12-14-35(52)70)63-48(83)34(20-37(73)74)67-43(78)29(11-9-17-58-50(55)56)64-49(84)38(53)24(3)4/h21-26,28-34,38-39,69H,7-20,51,53H2,1-6H3,(H2,52,70)(H2,54,75)(H,57,59)(H,60,77)(H,61,76)(H,62,81)(H,63,83)(H,64,84)(H,65,82)(H,66,79)(H,67,78)(H,68,80)(H,71,72)(H,73,74)(H4,55,56,58)/t25-,26+,28-,29-,30-,31-,32-,33-,34-,38-,39-/m0/s1
PDB
MMDB

UniProtKB/TrEMBL

B.MOAD
DrugBank
GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a>2.00E+6n/an/an/an/an/an/a



Graduate School of the Chinese Academy of Sciences

Curated by ChEMBL


Assay Description
Inhibition of wild type HIV1 integrase strand transfer activity


J Med Chem 49: 4477-86 (2006)


Article DOI: 10.1021/jm060307u
BindingDB Entry DOI: 10.7270/Q2736QJZ
More data for this
Ligand-Target Pair
C5a anaphylatoxin chemotactic receptor (C5aR)


(Homo sapiens (Human))
BDBM50012295
PNG
(CHEMBL217378 | ISHKDMQLGR | Ile-Ser-His-Lys-Asp-Me...)
Show SMILES CC[C@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O
Show InChI InChI=1S/C49H85N17O15S/c1-6-26(4)39(52)47(79)66-35(23-67)46(78)64-33(19-27-21-55-24-58-27)44(76)60-28(10-7-8-15-50)41(73)65-34(20-38(70)71)45(77)62-30(14-17-82-5)43(75)61-29(12-13-36(51)68)42(74)63-32(18-25(2)3)40(72)57-22-37(69)59-31(48(80)81)11-9-16-56-49(53)54/h21,24-26,28-35,39,67H,6-20,22-23,50,52H2,1-5H3,(H2,51,68)(H,55,58)(H,57,72)(H,59,69)(H,60,76)(H,61,75)(H,62,77)(H,63,74)(H,64,78)(H,65,73)(H,66,79)(H,70,71)(H,80,81)(H4,53,54,56)/t26-,28-,29-,30-,31-,32-,33-,34-,35-,39-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a>1.00E+6n/an/an/an/an/an/a



University of Queensland

Curated by ChEMBL


Assay Description
50% reduction in binding of [125I]-C5a to human polymorphonuclear cells (PMNs)


J Med Chem 41: 3417-25 (1998)


Article DOI: 10.1021/jm9800651
BindingDB Entry DOI: 10.7270/Q2C828FP
More data for this
Ligand-Target Pair
C5a anaphylatoxin chemotactic receptor (C5aR)


(Homo sapiens (Human))
BDBM50012295
PNG
(CHEMBL217378 | ISHKDMQLGR | Ile-Ser-His-Lys-Asp-Me...)
Show SMILES CC[C@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O
Show InChI InChI=1S/C49H85N17O15S/c1-6-26(4)39(52)47(79)66-35(23-67)46(78)64-33(19-27-21-55-24-58-27)44(76)60-28(10-7-8-15-50)41(73)65-34(20-38(70)71)45(77)62-30(14-17-82-5)43(75)61-29(12-13-36(51)68)42(74)63-32(18-25(2)3)40(72)57-22-37(69)59-31(48(80)81)11-9-16-56-49(53)54/h21,24-26,28-35,39,67H,6-20,22-23,50,52H2,1-5H3,(H2,51,68)(H,55,58)(H,57,72)(H,59,69)(H,60,76)(H,61,75)(H,62,77)(H,63,74)(H,64,78)(H,65,73)(H,66,79)(H,70,71)(H,80,81)(H4,53,54,56)/t26-,28-,29-,30-,31-,32-,33-,34-,35-,39-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 1.30n/an/an/an/a



University of Nebraska Medical Center

Curated by ChEMBL


Assay Description
Abilitiy to induce shape change (polarization) in human polymorphonuclear leukocytes (PMN)


J Med Chem 38: 3669-75 (1995)


Article DOI: 10.1021/jm00018a028
BindingDB Entry DOI: 10.7270/Q23777RC
More data for this
Ligand-Target Pair
ITGAV/ITGB3


(Homo sapiens (Human))
BDBM50187746
PNG
(CHEMBL384337 | RGDechi)
Show SMILES CSCCC(NC(=O)CCC1NC(=O)C(CC(O)=O)NC(=O)CNC(=O)C(CCCN=C(N)N)NC(=O)C(CCCCN)NC1=O)C(=O)NC(CC(O)=O)C(=O)NC(CC(O)=O)C(=O)N1CCCC1C(=O)NCC(=O)NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O
Show InChI InChI=1S/C84H134N30O29S/c1-41(67(127)111-66(42(2)115)82(142)143)99-78(138)56-18-10-27-112(56)62(120)39-97-70(130)45(14-4-6-23-85)103-74(134)50(31-43-36-92-40-98-43)107-79(139)57-19-12-29-114(57)80(140)53(32-58(88)116)108-68(128)44(87)13-8-26-94-84(91)110-61(119)38-96-77(137)55-17-11-28-113(55)81(141)54(35-65(125)126)109-76(136)52(34-64(123)124)106-73(133)49(22-30-144-3)100-59(117)21-20-48-72(132)104-47(15-5-7-24-86)71(131)102-46(16-9-25-93-83(89)90)69(129)95-37-60(118)101-51(33-63(121)122)75(135)105-48/h36,40-42,44-57,66,115H,4-35,37-39,85-87H2,1-3H3,(H2,88,116)(H,92,98)(H,95,129)(H,96,137)(H,97,130)(H,99,138)(H,100,117)(H,101,118)(H,102,131)(H,103,134)(H,104,132)(H,105,135)(H,106,133)(H,107,139)(H,108,128)(H,109,136)(H,111,127)(H,121,122)(H,123,124)(H,125,126)(H,142,143)(H4,89,90,93)(H3,91,94,110,119)/t41-,42+,44-,45-,46?,47?,48?,49?,50-,51?,52?,53-,54?,55?,56-,57-,66-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 880n/an/an/an/an/an/a



University of Naples Federico II

Curated by ChEMBL


Assay Description
Inhibition of adhesion of K562 cells expressing alphaVbeta3 integrin receptor to vitronectin


J Med Chem 49: 3416-20 (2006)


Article DOI: 10.1021/jm060233m
BindingDB Entry DOI: 10.7270/Q23X87V0
More data for this
Ligand-Target Pair
C5a anaphylatoxin chemotactic receptor (C5aR)


(Homo sapiens (Human))
BDBM50012295
PNG
(CHEMBL217378 | ISHKDMQLGR | Ile-Ser-His-Lys-Asp-Me...)
Show SMILES CC[C@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O
Show InChI InChI=1S/C49H85N17O15S/c1-6-26(4)39(52)47(79)66-35(23-67)46(78)64-33(19-27-21-55-24-58-27)44(76)60-28(10-7-8-15-50)41(73)65-34(20-38(70)71)45(77)62-30(14-17-82-5)43(75)61-29(12-13-36(51)68)42(74)63-32(18-25(2)3)40(72)57-22-37(69)59-31(48(80)81)11-9-16-56-49(53)54/h21,24-26,28-35,39,67H,6-20,22-23,50,52H2,1-5H3,(H2,51,68)(H,55,58)(H,57,72)(H,59,69)(H,60,76)(H,61,75)(H,62,77)(H,63,74)(H,64,78)(H,65,73)(H,66,79)(H,70,71)(H,80,81)(H4,53,54,56)/t26-,28-,29-,30-,31-,32-,33-,34-,35-,39-/m0/s1
PDB

KEGG

UniProtKB/SwissProt

GoogleScholar
CHEMBL
KEGG
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 12n/an/an/an/a



University of Nebraska Medical Center

Curated by ChEMBL


Assay Description
Release of beta-glucuronidase from human polymorphonuclear leukocytes(PMN)


J Med Chem 38: 3669-75 (1995)


Article DOI: 10.1021/jm00018a028
BindingDB Entry DOI: 10.7270/Q23777RC
More data for this
Ligand-Target Pair